Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Protalix BioTherapeutics
PLX
$190M
| $1.22M | ﹤0.01% |
210,130
-19,950
| -9% | -$128K |
|
|
ATTU
2502
DELISTED
Attunity Ltd
ATTU
| $1.22M | ﹤0.01% |
181,300
-8,100
| -4% | -$55.5K |
|
2503
FerroAtlántica
GSM
$818M
| $1.22M | ﹤0.01% |
+92,400
| New | +$1.2M |
|
2504
Ascendis Pharma A/S
ASND
$16.2B
| $1.21M | ﹤0.01% |
33,500
+8,030
| +32% | +$230K |
|
2505
Parke Bancorp
PKBK
$409M
| $1.21M | ﹤0.01% |
66,041
-1,573
| -2% | -$26.4K |
|
|
STZ.B
2506
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.21M | ﹤0.01% |
6,100
| – | – |
|
2507
Flotek Industries
FTK
$1.25B
| $1.21M | ﹤0.01% |
+43,263
| New | +$1.71M |
|
2508
First US Bancshares
FUSB
$90.6M
| $1.2M | ﹤0.01% |
104,700
+2,200
| +2% | +$24.7K |
|
|
QCP
2509
DELISTED
Quality Care Properties, Inc.
QCP
| $1.2M | ﹤0.01% |
77,700
+54,900
| +241% | +$872K |
|
2510
Resources Connection
RGP
$144M
| $1.2M | ﹤0.01% |
86,400
+24,400
| +39% | +$318K |
|
2511
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.19M | ﹤0.01% |
226,503
-178,000
| -44% | -$911K |
|
2512
Liberty Media Series A
FWONA
$23.7B
| $1.19M | ﹤0.01% |
33,971
-47,315
| -58% | -$1.59M |
|
2513
Virco
VIRC
$95.5M
| $1.19M | ﹤0.01% |
215,700
+14,967
| +7% | +$81.5K |
|
2514
Vaalco Energy
EGY
$592M
| $1.19M | ﹤0.01% |
1,445,400
+33,700
| +2% | +$27.3K |
|
|
LTS
2515
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $1.18M | ﹤0.01% |
410,800
+30,200
| +8% | +$75.2K |
|
2516
Digital Turbine
APPS
$1.53B
| $1.18M | ﹤0.01% |
782,174
+650,395
| +494% | +$769K |
|
|
FCCY
2517
DELISTED
1st Constitution Bancorp
FCCY
| $1.18M | ﹤0.01% |
65,000
+1,800
| +3% | +$31.2K |
|
|
APEX
2518
DELISTED
Apex Global Brands Inc. Common Stock
APEX
| $1.18M | ﹤0.01% |
14,283
-3,799
| -21% | -$520K |
|
|
PPIH
2519
Perma-Pipe International
PPIH
$216M
| $1.18M | ﹤0.01% |
138,300
+4,800
| +4% | +$39.1K |
|
|
CAW
2520
DELISTED
CCA Industries, Inc.
CAW
| $1.17M | ﹤0.01% |
348,000
+2,400
| +0.7% | +$8.37K |
|
2521
Oppenheimer Holdings
OPY
$1.23B
| $1.16M | ﹤0.01% |
67,100
+18,000
| +37% | +$294K |
|
2522
ClearOne Inc
CLRO
$15.2M
| $1.15M | ﹤0.01% |
10,327
-13
| -0.1% | -$1.65K |
|
2523
Ohio Valley Banc Corp
OVBC
$211M
| $1.15M | ﹤0.01% |
31,700
+3,307
| +12% | +$111K |
|
|
MBFI
2524
DELISTED
MB Financial Corp
MBFI
| $1.15M | ﹤0.01% |
25,600
+13,900
| +119% | +$576K |
|
|
CDTX
2525
DELISTED
Cidara Therapeutics
CDTX
| $1.15M | ﹤0.01% |
7,105
+330
| +5% | +$46.9K |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.